Prenuvo and UT Dallas researchers found links between sleep efficiency, visceral fat and brain volume, with long sleepers ...

Mission Therapeutics has begun a 36-patient Phase 1b study of MTX325, a drug aimed at clearing out damaged mitochondria in ...

Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning.

Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to Alzheimer’s.

The Boston company says the deal more than doubles its patient reach and opens a path to brain-based sleep testing in primary care from 2027.

United Therapeutics will test treprostinil SMI in about 40 patients with pulmonary hypertension linked to COPD.

A Biograph study using AI on routine heart CT scans found inflammation that cholesterol tests and risk calculators could not ...

XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling ...

Decades founder Eva Novak on why the blue zone idea can survive scrutiny, but only if validation becomes independent, open and repeated. In early October, a mountain village in central Sardinia was ...

Organoids are full of cells that shouldn’t be there, and sorting them out wrecks the vasculature. SynBITE prunes in place instead.